Grunenthal Meds

Grunenthal Meds

GrĂ¼nenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between GrĂ¼nenthal GmbH and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe.

Want to learn more?

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Grunenthal Meds
Grunenthal Meds Building 6, Galabank Business Park, Galashiels Selkirkshire TD11QH United Kingdom
Get directions

CPD Subsectors

Online & E-learning
Educational Resources
Health & Wellbeing
International Associations